George Kouvas joined the Wyss Center in February 2017 and was appointed as CTO in January 2020. With over 20 years of experience in medical devices, neurotechnology, pharma, eHealth, eBusiness and R&D services, Kouvas holds a Diploma in Electrical and Computer Engineering and an MBA, from the National Technical University of Athens (NTUA).

As CTO, George is responsible for the development and translation of the Wyss Center’s technology portfolio towards the clinic and the market. Under his leadership, one of the Wyss Center’s flagship programs, EPIOS™, evolved from initial idea to clinical-stage start-up, while other technology projects are being accelerated for human benefit.

George enjoys acting as an expert and evaluating technology innovation projects and proposals. He is passionate about helping the community bring innovations to life.

Prior to joining the Wyss Center, he was a Director and Technical leader of Merck’s eHealth platform in Switzerland, where he managed the development and market-launch of disease management solutions for several therapeutic areas. Earlier in his career he held various engineering and management roles, coordinating consortiums of technology, business and academia partners in innovation projects.